Non small cell lung cancer diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
Line 52: Line 52:
===Diagnostic modality for staging===
===Diagnostic modality for staging===
Staging of cancer and extent of metastasis can be diagnosed by various methods.
Staging of cancer and extent of metastasis can be diagnosed by various methods.
* '''Endobronchial ultrasound:''' First-line diagnostic modality for mediastinal staging.
* '''Endoscopic ultrasound:'''  
 
** First-line diagnostic modality for mediastinal staging.
* The sensitivity of endobronchial ultrasound.<ref name="pmid24484269">{{cite journal |vauthors=Kinsey CM, Arenberg DA |title=Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging |journal=Am. J. Respir. Crit. Care Med. |volume=189 |issue=6 |pages=640–9 |year=2014 |pmid=24484269 |doi=10.1164/rccm.201311-2007CI |url=}}</ref><ref name="cancer">Tests for non-small cell lung cancer. American Cancer Society. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-diagnosis Accessed on February 25, 2016</ref>
** Endobronchial and endoscopic esophageal ultrasound are mainly use to
 
** The sensitivity of endobronchial ultrasound.<ref name="pmid24484269">{{cite journal |vauthors=Kinsey CM, Arenberg DA |title=Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging |journal=Am. J. Respir. Crit. Care Med. |volume=189 |issue=6 |pages=640–9 |year=2014 |pmid=24484269 |doi=10.1164/rccm.201311-2007CI |url=}}</ref><ref name="cancer">Tests for non-small cell lung cancer. American Cancer Society. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-diagnosis Accessed on February 25, 2016</ref>
*On ultrasound (endobronchial ultrasound), characteristic findings of non-small cell lung cancer include:
** On ultrasound (endobronchial ultrasound), characteristic findings of non-small cell lung cancer include:
**Enlarged lymph nodes  
****Enlarged lymph nodes  
**Local invasion of adjacent [[bronchial]] structures and [[mediastinum]]
****Local invasion of adjacent [[bronchial]] structures and [[mediastinum]]


* Indications for the endobronchial ultrasound:
* Indications for the endobronchial ultrasound:

Revision as of 19:22, 8 January 2019

Non Small Cell Lung Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non Small Cell Lung Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Approach

Stage I
Stage II
Stage III
Stage IV
Metastatic Cancer

Medical Therapy

Chemotherapy
Radiation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non small cell lung cancer diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non small cell lung cancer diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non small cell lung cancer diagnostic study of choice

CDC on Non small cell lung cancer diagnostic study of choice

Non small cell lung cancer diagnostic study of choice in the news

Blogs on Non small cell lung cancer diagnostic study of choice

Directions to Hospitals Treating Non small cell carcinoma of the lung

Risk calculators and risk factors for Non small cell lung cancer diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Trusha Tank, M.D.[2],Furqan M M. M.B.B.S[3]

Overview

Chest X-Ray is the initial study performed when non-small cell lung cancer is suspected. Lung CT scan is the diagnostic study of choice for the diagnosis of non-small cell lung cancer. Endobronchial ultrasound is a first-line diagnostic modality for the mediastinal staging of the non-small cell lung cancer. The lung biopsy is the gold standard for the diagnosis of the non-small cell lung cancer. The lung biopsy helps to differentiate between the various subtypes of lung cancer.

Diagnostic Study of Choice

Study of choice

Non small cell cancer of the lung is diagnosed by the following approach:[1]

  • Chest X-Ray is the initial study performed when non-small cell lung cancer is suspected.
  • The next step in diagnosing non small cell carcinoma of the lung is contrast-enhanced computed tomography (CT).
  • On CT, characteristic findings of non-small cell lung cancer include:[2]
    • Centrally located tumors, invading the mediastinal structures
    • Peripherally located tumors, invading the pleura and chest wall
    • Tumor margins: Smooth, lobulated, irregular and spiculated
    • Tumor density: Uniformly solid; central necrosis; cavitation (squamous histology)
    • Area of consolidation in the pulmonary field
    • Ground-glass opacity (GGO)
    • Air bronchogram
    • Pleural or pericardial perfusion
  • When the imaging study suggests lung cancer, diagnosis must be confirmed by performing a transthoracic, bronchoscopic or an image-guided biopsy depending upon the location of the tumor.[3]

Gold standard

  • Lung biopsy is the gold standard test for the diagnosis of non-small cell lung cancer.
  • The diagnostic result of lung biopsy is confirmatory of non-small cell lung cancer and depends on the type of cancer. Click here to view the biopsy findings of the subtypes.

Evaluation Algorithm for Suspected Non-Small Cell Lung Cancer

The algorithm below summarizes the initial imaging approach for patients with suspected non-small cell lung cancer.[1][4]


 
 
 
 
 
Imaging approach
❑ Suspected lung cancer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chest X Ray normal?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enhanced Computed Tomography (ECT), includes:
❑ Thorax
❑ Upper Abdomen
❑ Low Neck
 
 
 
Manage and observe
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Imaging evaluation
 
 
 
 
 
 
 
 
 
 
 
 
 
Location
❑ Central
❑ Peripheral
❑ Pleural lesion
Size
Lesion characteristics
❑ Margins (irregular/regular)
❑ Shape (spiculated/rounded)
Presence of cavitation
❑ Yes
❑ No
Type of adenopathy
❑ Hiliar
❑ Mediastinal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Imaging or Diagnostic Modalities
❑ Sputum cytology
❑ Bronchoscopy
❑ Mediastinoscopy
❑ PET/CT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Diagnostic modality for staging

Staging of cancer and extent of metastasis can be diagnosed by various methods.

  • Endoscopic ultrasound:
    • First-line diagnostic modality for mediastinal staging.
    • Endobronchial and endoscopic esophageal ultrasound are mainly use to
    • The sensitivity of endobronchial ultrasound.[3][5]
    • On ultrasound (endobronchial ultrasound), characteristic findings of non-small cell lung cancer include:
  • Indications for the endobronchial ultrasound:
    • Evaluation of lymph nodes and other structures in the mediastinum
    • Mediastinal invasion staging
    • Determination of management strategy
    • Real-time evaluation of structures

Staging

  • Staging system classifications for non-small cell lung cancer include:[6][7]
  • American Joint Committee on Cancer (AJCC) staging system
  • International Union Against Cancer (UICC) staging system

American Joint Committee on Cancer (AJCC) Staging

  • The table below summarizes the TNM staging system for the diagnosis of non-small cell lung cancer.[6]
TNM Description
TX The primary tumour cannot be assessed, or there are malignant cells in the sputum or bronchoalveolar lavage but not seen on imaging or bronchoscopy
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumour less than 3 cm in its greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic invasion into the main bronchus.
T2 A tumour with any of: More than 3 cm in greatest dimension; Extending into the main bronchus, but more than 2 cm distal to the carina; Obstructive pneumonitis, but not involving the entire lung
T3 A tumour with any of: Invasion of the chest wall, diaphragm, mediastinal pleura, or parietal pericardium; Extending into the main bronchus, within 2 cm of the carina, but not involving the carina; Obstructive pneumonitis of the entire lung
T4 A tumour with any of: Invasion of the mediastinum, heart, great vessels, trachea, oesophagus, vertebra, or carina; Separate tumour nodules in the same lobe; Malignant pleural effusion
Regional Lymph Nodes
NX Lymph nodes cannot be assessed
N0 No lymph nodes involved
N1 Metastasis to ipsilateral peribronchial or ipsilateral hilar lymph nodes
N2 Metastasis to ipsilateral mediastinal or subcarinal lymph nodes
N3 Metastasis to any of: Ipsilateral supraclavicular lymph nodes; Ipsilateral scalene lymph nodes; Contralateral lymph nodes.
Distant Metastasis
MX Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis is present

International Union Against Cancer (UICC) Staging System

  • The table below summarizes the TNM staging system for the diagnosis of non-small cell lung cancer.[6]
Stage T N M
Occult carcinoma TX N0 M0
Stage 0 Tis N0 M0
Stage IA T1 N0 M0
Stage IB T2 N0 M0
Stage IIA T1 N1 M0
Stage IIB T2 N1 M0
T3 N0 M0
Stage IIIA T1 N2 M0
T2 N2 M0
T3 N1 M0
T3 N2 M0
Stage IIIB Any T N3 M0
T4 Any N M0
Stage IV Any T Any N M1

References

  1. 1.0 1.1 Purandare, NilenduC; Rangarajan, Venkatesh (2015). "Imaging of lung cancer: Implications on staging and management". Indian Journal of Radiology and Imaging. 25 (2): 109. doi:10.4103/0971-3026.155831. ISSN 0971-3026.
  2. Kundel HL (1981). "Predictive value and threshold detectability of lung tumors". Radiology. 139 (1): 25–9. doi:10.1148/radiology.139.1.7208937. PMID 7208937.
  3. 3.0 3.1 Kinsey CM, Arenberg DA (2014). "Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging". Am. J. Respir. Crit. Care Med. 189 (6): 640–9. doi:10.1164/rccm.201311-2007CI. PMID 24484269.
  4. WHO: Lung cancer/Tumours of the Lung. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on March 1, 2016
  5. Tests for non-small cell lung cancer. American Cancer Society. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-diagnosis Accessed on February 25, 2016
  6. 6.0 6.1 6.2 Stages of non–small cell lung cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/lung/staging/?region=ab
  7. Horn, Leora, et al. "Neoplasms of the Lung." Harrison's Principles of Internal Medicine, 19e. Eds. Dennis Kasper, et al. New York, NY: McGraw-Hill, 2015. n. pag. AccessMedicine. Web. 1 Mar. 2016. <http://accessmedicine.mhmedical.com.ezp-prod1.hul.harvard.edu/content.aspx?bookid=1130&Sectionid=69857702>.

Template:WH Template:WS